AstraZeneca CFO: 'We've come a long way in our oncology portfolio' [Yahoo! Finance Canada]
![Yahoo! Finance Canada](../../../Content/images/providers/Yahoo! Finance Canada.png)
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance Canada
The company has since withdrawn the vaccine due to low demand and rare side effects, but is once again an investor favorite after sharing recent data on its cancer drugs. One of its best-performing lung cancer drugs, Tagrisso, first approved in 2017, has proven it can reduce the risk of disease progression by 84% in patients with a type of Stage 3 lung cancer. Those results won it a standing ovation from attendees at the recent American Society of Clinical Oncology conference in Chicago. The company also revealed a CAR-T therapy candidate — an immunotherapy that is crafted from a person's own immune system to fight cancer — that could reduce tumors in liver cancer patients. In addition, the company is working on a new breast cancer treatment. A bottle of Tagrisso on a table at a home in Deerfield, Ill. (AP Photo/Nam Y. Huh) (ASSOCIATED PRESS) All of this means the company is gearing up for several launches and label expansions — and new revenue streams. AstraZeneca has set a ta
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Smart Packaging and Electronic Patient Information Training Course: Building Blocks for the Establishment and Delivery of e-PIL and SMART Strategic Initiatives (ONLINE EVENT) [Yahoo! Finance]Yahoo! Finance
- AstraZeneca's Truqap flops in Phase III triple negative breast cancer trial [Yahoo! Finance]Yahoo! Finance
- Unaudited Interim Results [Yahoo! Finance]Yahoo! Finance
- SAS expands portfolio of data and AI solutions for life sciences and health care [Yahoo! Finance]Yahoo! Finance
- Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to Women Undergoing Breast Cancer Treatment [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 6/18/24 - Form 6-K
- 6/17/24 - Form 6-K
- 6/12/24 - Form 6-K
- AZN's page on the SEC website